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Abstract: Biosensors devices have attracted the attention of many researchers across the world.
They have the capability to solve a large number of analytical problems and challenges. They are future
ubiquitous devices for disease diagnosis, monitoring, treatment and health management. This review
presents an overview of the biosensors field, highlighting the current research and development of
bio-integrated and implanted biosensors. These devices are micro- and nano-fabricated, according
to numerous techniques that are adapted in order to offer a suitable mechanical match of the
biosensor to the surrounding tissue, and therefore decrease the body’s biological response. For this,
most of the skin-integrated and implanted biosensors use a polymer layer as a versatile and flexible
structural support, combined with a functional/active material, to generate, transmit and process
the obtained signal. A few challenging issues of implantable biosensor devices, as well as strategies
to overcome them, are also discussed in this review, including biological response, power supply,
and data communication.
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1. Introduction
All the manifested interest in biosensors started with the first invention of a glucose biosensor based
on an oxygen electrode by Leland Clark in 1962 [1]. Since then, there have been many improvements
and discoveries in the field. The concept of a biosensor is defined as a bio-analytical device, capable of
providing specific quantitative and semi-quantitative analytical information by converting biological
reactions or stimulus into measurable signals. Essentially, it comprises three essential components,
a biological sensing component, connected to a detector or transducer component, and a signal
processing system [2–4]. The biological element can be an antibody, a nucleic acid, an enzyme,
a cell, or many others. A transducer depends on transduction methods, as electrochemical, optical,
calorimetric or acoustic [2].
Biosensors have shown to be very helpful in our daily life and to play a relevant role in agriculture,
food safety, homeland security, bioprocessing, environmental and industrial monitoring. However,
biosensing in medicine is the most promising application of the field, since there is a need for new
and improved devices with sensitivity, specificity, reliability and biocompatibility for the diagnosis,
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monitoring and treatment of several health conditions. Additionally, to the troubleshooting, real-time
monitoring and management of health problems, biosensors must also be able to simultaneously detect
multiple analytes or stimulus, within biological fluids, outside and inside the body [2].
The demand for constant monitoring of vital signs aims to solve the issue related to the conventional
need of hospitalization and supervision of the patient. Therefore, several studies have been made
in researching and developing skin-integrated and implantable medical devices. In these devices,
the most often monitored vital signs are heart electrical signals, blood pressure, pulse rate, blood glucose
level, and respiration efficacy [5]. Advances in this field have provided freer patient motion and
uninterrupted diagnostic data streams for medical monitoring [6].
In a biomedical context, biosensors need specific requirements, such as biocompatibility
(sometimes, biodegradability and/or bioresorbability), miniaturization and reliability. Specifically,
skin-integrated devices must be, in addition, flexible, stretchable, lightweight, and ultra-thin, allowing
them to be able to conform and also to support all the constant motions of the skin in a non-discomforting
way. Implantable devices also require all of those characteristics in order to not trigger or minimize any
immune response and/or biofouling; to adapt to 3D organ’s shapes and to exclude the need of complex
surgery. Nevertheless, there are some factors that limit the advances of this kind of implantable device
and which are related to foreign body response (FBR), continuous and enough power supply that do
not demand heavy and bulky batteries/electronics and data transmission without the need of wires.
All this progress in biosensors field has opened new routes to improve the medical care, diagnostic
systems and the patient’s commodity.
The aim of this review is to give a brief overview in the biosensors field, exploring their types,
function modes, and applications, with particular emphasis on the state-of-the-art of skin-like and
implantable biosensors.
2. Biosensors Overview
A biosensor is an analytical device composed by a biological recognition element in direct spatial
contact with a physical transduction element. Biosensors generally consist of three fundamental
components: (i) the detector, to detect the stimulus or the biological component; (ii) the transducer,
to permute the stimulus in an output signal; and (iii) the signal processing system, to process the
output signal in an appropriate form. The proper combination of these three elements leads to a rapid
and convenient conversion of the biological events to detectable and measurable signals [5,6].
These biological sensors can be broadly classified into different categories, based either on the
sensing components or on the transducer components, as shown in Figure 1. Hence, on the basis of the
different biological sensing elements, including enzymes, microbes, organelles, cells and biological
tissues, biosensors can be categorized as catalytic biosensors, or affinity biosensors when including
nucleic acids, antibodies or receptors. Generally, the biological recognition or sensing element consists
of one of those mentioned biocomponents, immobilized in a transducer platform, able to detect the
specific target analyte. The type of physiological change derived from the sensing event will set
the transducing mechanism. According to the transduction component, biosensors can be grouped
into electrochemical (conductimetric, amperometric, impedimetric and potentiometric) [7], optical
(fluorescence, absorbance and chemiluminescence) [8], calorimetric [9] and acoustic [10].
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the formation’s rate of a product, disappearance of a reactant, or the inhibition of the reaction [11–
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Affinity-based biosensors base their principle of action on the fact that stable and selective 
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well-known affinity biosensor is the enzyme-linked immunosorbent assay (ELISA) [11]. This kind of 
biosensor is developed to improve association and diminish dissociations of target analytes. 
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production of a new chemical, flow of electrons and changes in pH or mass, originating from a 
biochemical signal. To detect a small amount of this signal, the biorecognition event (e.g., chemical 
binding, micromechanical response, or a change in cell behavior) must be converted by the 
transducer into an electric signal, and amplified in order to be possible its quantification, display and 
comparison to estimated values [2,16,17]. There are a variety of transducer methods which are 
constantly being developed through the years for use in biosensors. The most common can be 
grouped into electrochemical, optical, acoustic and calorimetric. 
An electrochemical transduction element can sense out, and use as a measuring parameter, some 
change in the electric properties derived from the production or consumption of ions or electrons of 
the biorecognition reactions. Typically, these reactions may either generate a measurable potential or 
charge accumulation (potentiometric biosensor), a measurable current (amperometric biosensor), a 
measurable conductance (conductimetric) or measuring resistive and capacitive changes 
(impedimetric biosensor) between electrodes. Electrochemical biosensors are commonly composed 
by three electrodes: a reference electrode, a working electrode and a counter electrode, although they 
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2.1. Biosensors by Type of Bioreceptor: Catalytic and Affinity Biosensors
Bioreceptors are bond to the transducers surface, and are responsible for the specific binding
of the analyte, as well as the physical-chemical mechanism that will originate the biosensor signal.
Catalytic sensing is based on a catalyzed chemical conversion of the analyte from a non-measurable
form to a detectible form. The progress of the biocatalysis can be monitored through a detection of
the formation’s rat f a product, disappearance of a reactant, or the i hibition of the rea tion [11–13].
Enzymes be ong most y to the gr up of proteins, with the exception of a small group of catalytic
ribonucleic acid molecules. Glucose oxidase (GOD) is the enzyme most widely used in enzyme-based
biosensors [11,14].
Affinity-based biosensors base their principle of action on the fact that stable and selective
sensing complexes undergo important affinity interactions between the analyte and the immobilized
biomolecule on the transduction element. The interactions occur through non-covalent binding of
several functional groups in a short time, resulting in a measurable signal. These mentioned affinity
complexes include antigen–antibody, DNA-oligonucleotides or protein–protein complexes [11,15].
A well-known affinity bios nsor is he enzyme-li ked immunosorbent assay (ELISA) [11]. Thi kind of
biosensor is developed to improv association and diminish dissociations of t rget analytes. However,
they easily become saturated and do not provide dynamic information about variations in the level of
the analyte over time. So, as the binding may not be reversible, they cannot be regenerated and may
not be applied for long-term analyte monitoring [11].
2.2. Biosensors by Type of Signal Transduction
The reaction between the analyte and bioreceptor causes some changes, such as release of
heat, production of a new chemical, flow of electrons and changes in pH or mass, originating
from a biochemical sign l. To d tect a small amount of this signal, the biorecognition event (e.g.,
chemical bi ding, micromechanical response, or a change in cell behavior) ust be converted by the
transducer into an electric signal, and mplified in order to be possible its quantification, display
and comparison to estimated values [2,16,17]. There are a variety of transducer methods which are
constantly being developed through the years for use in biosensors. The most common can be grouped
into electrochemical, optical, acoustic and calorimetric.
An electrochemical transduction element can sense out, and use as a measuring parameter,
some change in the electric properties derived from the production or consumption of ions or
electrons of the biorecognition reactions. Typically, these reactions may either generate a measurable
potential or charge accumulation (potentiometric biosensor), a measurable current (amperometric
biosensor), a measurable conductance (conductimetric) or measuring resistive and capacitive changes
(impedimetric biosensor) between electrodes. Electrochemical biosensors are commonly composed by
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three electrodes: a reference electrode, a working electrode and a counter electrode, although they can
be composed by only two or more than three [16,18]. In electrochemical biosensors, signal-to-noise
ratio is key for detection, especially in wearable and implantable systems where concomitant noise is
significant [19,20].
Optical transducers use changes in optical properties resultant from the interaction between
biorecognition elements with the target analyte at the transducer’s surface, including absorption,
fluorescence, reflectance, emission or a change in an interferometric pattern. In other words, optical
biotransducers collect information about an analyte through photons. Variations in concentration,
mass or number of molecules are measured by a photodetector and, then, transformed into an electrical
signal [2,16,21].
Calorimetric transducers measure variations of temperature caused by the biochemical reaction
that happens when the target analyte binds the biorecognition element. The change in temperature can
be related to the amount of reactants consumed or products formed, and measured using a thermistor
or a thermopile [2].
Finally, acoustic transducers are based on either the bulk acoustic wave or the surface acoustic
wave. Transduction is made through the detection of changes in their physiochemical properties as
mass density, elastic, viscoelastic or electrical conduction properties, hence following a piezoelectric
effect [16].
3. Biosensors in Medicine
Biosensors, as a fast-growing field by virtue of their ability to drastically help a number of analytical
challenges and problems, have found applications in distinct areas, like agriculture and food safety,
environmental monitoring, biotechnology, genetic engineering, pharmacology, defense, homeland
security, industry, and essentially, in medicine and health care. In agricultural industry, biosensors
are used for certain cases such as enzymes biosensors, to detect organophosphates and carbamates
from pesticides, microbial biosensors for measurement of methane and ammonia, and bacteria-based
biosensors for wastewater quality control. Regarding the food industry, biosensors are being used to
measure amino acids, carbohydrates, inorganic ions, alcohols, acids, etc. [16,22,23].
Despite all the mentioned application areas, the most popular and with enormous potential is the
application in medicine and biomedical diagnosis. This potential is driven by the need to solve medical
and health problems including diabetes, cancer, chronic diseases such as heart disease, respiratory
diseases, stroke, obesity, and so many others. Hence, measurements that are being established in health
care are related to blood metabolites like glucose, lactate, and urea, and also to cancer biomarkers,
folic acid, biotin, vitamin B12 and pantothenic acid [22].
The first introduction of a biosensor in medicine was in 1962, with the development of an
amperometric enzyme electrode (platinum) for a glucose sensor by Leland C. Clark and Champ Lyons.
These platinum electrodes detected oxygen as a result of the change on the enzymatic activity of the
enzyme glucose oxidase which was entrapped with a dialysis membrane at the electrodes, depending
on the surrounding concentration of oxygen [1,23]. Since then, glucose biosensors have so far been the
most frequent, and many other biosensors have been developed for medicine, regarding improvements
in the sensitivity, selectivity, and multiplexing capacity.
Lately, there is a growing interest in the application of biosensors in tissue engineering, notably in
microfluidic tissue engineering models, since they can help sense specific biological molecules within
the miniaturized tissue constructs in real-time, by means of ultrasensitive optical, electrochemical,
or acoustic systems [16,24].
In medical and biomedical fields, biosensors must be very accurate, reliable, and should exhibit a
high long-term stability with very little drift, and be resistant to the application of mechanical force,
such as the ones generated by pulsatile blood flow [25,26]. Furthermore, implantable or wearable
medical devices also need to be small, or otherwise they can be uncomfortable and bulky for the
patient, especially when employed in confined volume areas, like blood vessels, lungs or the brain.
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In addition, biosensors should not affect the measurement environment or patient’s well-being [27].
Although more challenging in terms of technology advances, both implantable and wearable devices,
have in common the fact that they allow the collection of vital signals information (such as heart rate,
respiration rate, skin temperature) and consequently, the monitoring of patients’ health over long
periods of time.
3.1. Skin-Integrated Wearable Biosensors
A strategy to perfectly integrate electronics with the human body is the approach of skin-mounted
epidermal electronics systems (EES) which provides a route to non-invasive continuous monitoring
of clinically important physiological signals, such as skin temperature, heart rate, blood pressure,
pulse and respiration rate, and transmits that information to the patient and the physician [25].
In addition to the assessment of these clinically relevant physiological parameters, sweat, saliva and
tears also contain multiple physiology chemical constituents [26].
The use of this type of sensors holds considerable promise for maintaining and improving quality
of life and consequently overrates the traditional systems. These traditional systems are known to
possess wires or cables, point-contact electrodes affixed to the skin with adhesive pads, mechanical
clamps or straps, or penetrating needles, mostly mediated by conductive gels. Besides that, they are also
poorly suited for practical applications outside of clinical settings, because they can cause discomfort,
irritation and inflammation to the user, lose adhesion over time, lack mobility, be generally very bulky
due to their robust, plan and hard formats and components and only allow the monitoring of one
physiological signal [25].
EES are skin-integrated stretchable devices, which are ultrathin, soft, low modulus, lightweight,
and skin-like sheets, that can be intimately and physically mounted on the rough epidermis via van
der Waals forces alone, without any mechanical fixation hardware or adhesive tapes. The EES with
skin similar mechanical properties can act as a “secondary skin”. Thus, it can conformably adhere
and laminate onto the surface of the skin by soft contact, in a way that is mechanically invisible and
imperceptible to the patient, much like a temporary transfer tattoo. They also can be easily applied to
any location on the patient’s skin [25,26,28]. At the end, they are natural interfaces capable to adapt and
accommodate motions of the skin with no mechanical constraints, establishing a robust, non-irritating
skin/electrode contact and allowing an intimate integration of diverse classes of electronic and sensor
technologies directly with the body [29].
Considering that skin is the protective barrier between the internal body systems and the
surrounding environment, every device that will be in contact with skin requires different design and
fabrication principles, in order to mimic its particular mechanophysiological properties, and does
not constrain or alter its natural motions or behaviors. Biocompatibility is also a requirement for this
device, in order to avoid body-foreign response. Diverse electronic devices able of being flexible and
stretchable have then been reported [26,30].
Flexible and stretchable electronic devices are usually built on substrates that reflect the
flexibility and stretchability of the human skin, and subsequently these substrates are engineered
using innumerous fabrication technologies, and material blends, in order to achieve the desired
properties. Skin has a remarkably property of accommodating body movements concurrently to
sensing functionalities, and thus needs exceptional flexibility and capability to stretch to ~30%
strain. Skin-like flexibility provided to electronic devices can be achieved by using soft and flexible
substrates and electronics, reducing the thickness of the substrate to lower the bending-induced strains,
or arranging the active components of the device within the materials at a position that does not suffer
strain during bending. Imparting stretchability involves two different strategies, such as engineering
the shape of traditional (non-stretchable) electronic materials and the implementation of intrinsically
stretchable components [31]. A strategic patterning of metallic components (metal, semiconductor
and insulator) into optimized “horseshoe” or “serpentine” shapes allows the net to deform drastically,
with little effect on its functionality [32].
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Attaching epidermal devices to the skin can be accomplished through directly mounting the
device onto a thin elastomeric supporting substrate or directly onto the skin [33]. This means that in the
first approach the electronic components will be integrated firstly onto a stretchable substrate through
printing techniques, following some 2D, such as discontinuous patterning and horseshoe or serpentine
shapes; or even using 3D patterns, like ‘buckling’ a material by depositing a high-modulus material
on a pre-stretched elastomer, followed by releasing the pre-strain, resulting in wave structures [34].
Following this type of integration, electronics can also be integrated directly, with a commercial
temporary transfer tattoo as a substrate alternative to elastomeric materials [35]. The second approach
is based on mounting the EES device directly onto the skin. This can be achieved either placing
the EES on the surface of an elastomeric stamp and then transfer printing directly onto the skin,
using a spray-on-bandage as an adhesive to facilitate the transferring and improve the robustness of
integration; or either transferring the EES to a water soluble polymeric layer, e.g., PVA (poly(vinyl
alcohol)), that will be further washed away after mounting on the skin, in order to leave only the EES.
In this case, a layer of spray-on-bandage can also be applied [29,31].
Several skin-integrated devices have been developed in the past 10 years, either by mounting
electronics onto a flexible substrate or directly onto the skin [33,35]. The first approach is more popular,
and several reports can be found on the integration of electronics onto stretchable elastomers by 2D
or 3D patterns. For example, Bao and his group produced transparent, stretchable and conducting
single-walled carbon nanotubes (SWCNTs) films, by spray-depositing directly onto a substrate of
poly(dimethylsiloxane) (PDMS) [36]. Chang and coworkers prepared a flexible pressure sensor using
vertically aligned carbon nanotubes (VACNTs) supported by a PDMS matrix, which maintained their
structural flexibility upon repeated compression (Figure 2a) [37]. PDMS is a common material to
produce skin wearable flexible substrates, originating several types of sensors due to its chemical
properties, biological compatibility, transparency, and good thermal stability, and especially its adhesion
and non-adhesion areas that are clearly visible under UV light and can be easily adhered to the surface
of electronic materials [38].
3.1.1. Sweat Sensors
Using sweat as a particular case of study, Khodagholy et al. showed a solid state electrolyte on a
flexible transistor-based biosensor that can be used as a wearable bandage type sensor for detection of
lactate [39]. Moreover, Koh et al. presented a collection of materials and device designs for soft, flexible,
and stretchable microfluidic systems, including embodiments that integrate wireless communication
electronics, which can intimately and robustly bond to the surface of the skin without chemical and
mechanical irritation. This integration defines access points for a small set of sweat glands, such that
perspiration spontaneously initiates routing of sweat through a microfluidic network and a set of
reservoirs. Embedded chemical analyses respond in colorimetric fashion to markers such as chloride
and hydronium ions, glucose, and lactate. Human studies demonstrated the functionality of this
microfluidic device during fitness cycling in a controlled environment, and during long-distance
bicycle racing in arid, outdoor conditions (Figure 2b) [40]. Finally, Xuan et al. reported a wearable
graphene oxide (rGO)-based nanostructured composite working electrode deposited onto a flexible
polyimide substrate for the electrochemical detection of glucose in human sweat when in close contact
with human skin through a water-proof adhesive band [38]. Indeed, finding ways to capture and store
the sweat in a controlled fashion is important for the further development of skin wearable biosensors.
Some studies have reported hydrogels loaded with acetylcholine and iontophoretic induce local sweat
accumulation for further analysis [41]. Alternative approaches rely on sudomotor axon reflex sweating
produced via iontophoresis of a nicotinic agonist, using a wearable iontophoretic electrode [42,43].
3.1.2. Bio-Potential Sensors
Liang et al. reported the fabrication of transparent thin-films transistors that behave like an
elastomer film by infiltrating a SWCNTs network and printing silver nanowires in an elastomeric
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dielectric film. Kang et al. developed a system (Figure 2f) for the direct observation of glucose Raman
peaks from in vivo pig’s skin. The experiments allowed a wide range of glucose concentrations and
long integration times to obtain Raman spectra. The glucose concentrations were controlled through
the injection of dextrose solution and insulin. Raman spectra were measured from the pig ears, with a
high optical throughput Raman system confirming the presence of glucose and the linearity between
its concentration and Raman peaks [44].
Son and coworkers presented a wearable bio-integrated system containing nanomembranes,
as strain sensors and resistive random access memory (RRAM) array, a temperature sensor,
and electroresistive heaters, heterogeneously fabricated and transfer-printed onto an elastomeric
hydrocolloid patch, for monitoring movement disorders [45]. Nanomaterials such as SWCNTs,
VACNTs, rGO, and nanomembranes are commonly used in wearable skin sensors, since they can
highly improve the specific signal over the background noise characteristic of human fluids [46,47].
Moreover, for human motion monitoring, Wang et al. prepared a flexible and wearable strain sensor
by adhering graphene woven fabrics on polymer and medical tape composite film, which proved to be
molded around human skin without any irritation symptoms [48]. Miyamoto et al. demonstrated
substrate-free electronics based on a conductive nanomesh structure, and showed the successful
fabrication of inflammation-free, highly gas-permeable, ultrathin, lightweight and stretchable sensors
that can be directly laminated onto human skin for long periods of time. Furthermore, a wireless
system that can detect touch, temperature and pressure was successfully demonstrated using the
nanomesh with excellent mechanical durability, and electromyogram recordings were successfully
taken with minimal discomfort to the user [49].
3.1.3. Tattoo-Like Sensors
Finally, temporary tattoos represent quite attractive platforms for preparing body-compliant
wearable devices capable of extracting good information from the epidermis [26]. Thus, bearing that in
mind, reports of tattoo-like sensors started to emerge, using flexible substrates for electronic integration.
Bandodkar and Wang group introduced tattoo-like electrochemical sensors, capable of mimic the
epidermis and create a good adhesion to it, for the enzymatic amperometric biosensing of lactate in
human perspiration (Figure 2c) [50] and glucose [51], or for the potentiometric biosensing of sweat pH
(Figure 2d), [52] and ammonium [53]. Furthermore, they also developed a tattoo-based potentiometric
sensor, coupled with a miniaturized wearable wireless transceiver, for the room temperature monitoring
of sodium in the human perspiration [54]. Furthermore, Rogers group [25] established the concept
‘epidermal electronics’ by laminating devices onto the skin composed by sensors for temperature and
strain and supporting electronics such as transistors, ring oscillators, diodes and radio frequency (RF)
inductors in serpentine patterns.
The promising devices that use electronic integration directly on skin were demonstrated by
Rogers group [29], that have figured out how to print multifunctional electronics right on the skin,
without an elastomer backing using a rubber stamp to deliver the ultrathin mesh electronics. They also
envisioned the use of a “spray-on-bandage” to add a thin protective layer and bond the system
to the skin. The Bandodkar group used elastomeric stamps to print electrodes directly on human
epidermis, associated to the use of wetting customized stamps with conductive inks pursued by
contact. Current efforts and challenges reside in the miniaturization and integration of the electronic
interface, data processing, wireless transmission of the results and the absence of re-calibration.
Therefore, with continued innovation, it is expected that skin-like devices will play a major role in
the emergent body sensors for diverse applications [26].
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Figure 2. Skin-integrated biosensor technologies. (a) Carbon nanotube-based pressure sensor for
flexible electronics. (i) Photograph of vertically aligned carbon nanotubes (VACNTs) on a Si substrate;
(ii) SEM images of VACNTs. The inset shows a high-magnification image highlighting the CNT
alignment. (iii) Electrical resistance versus pressure for a VACNT block [37]. (b) A soft, wearable
microfluidic device for the capture, storage, and colorimetric sensing of sweat. (i) Optical image of
a fabricated device mounted on the forearm. (ii) FEA results of stress distribution associated with
devices on phantom skin (PDMS) and respective optical images under various mechanical distortions:
stretching at 30% strain, bending with 5 cm radius, and twisting [40]. (c) Electrochemical Tattoo for
Real-Time Lactate Monitoring in Human Perspiration: monitoring of sweat lactate during 33 min
of cycling exercise while changing the work intensity. (i) Exercise resistance profile on a stationary
cycle. Subjects were asked to maintain a constant cycling rate, while the resistance was increased every
3 min for a total evaluation of 30 min. A 3-min cool down period followed the exercise. (ii) An “NE”
lactate biosensor applied to a male volunteer’s deltoid; (iii and iv) Response of the LOx- (a) and
enzyme-free (b) tattoo biosensors during the exercise regimen (shown in part i) using two representative
subjects. Constant potential, +0.05 V (vs. Ag/AgCl); measurement intervals, 1 s [52]. (d) Tattoo-based
potentiometric ion-selective sensors for epidermal pH monitoring. (e) Influence of repeated mechanical
strain (stretching) upon the response of the tattoo ISE: (i) pH-responsive behavior of the ISE tattoo
sensor prior to stretching (black) and following the 40th (red) stretch on GORE-TEX; one-unit pH
decrement per addition. (ii) Images of the tattoo applied to the forearm at normal, during stretching,
and after the 10th stretch [54]. (f). Raman spectroscopy system, actual probe setup with a subject,
and glucose profile during experiment. (i) Schematic diagram of Raman spectroscopy system for
in vivo animal (swine) skin measurement. (ii) Photograph of Raman probe setup. (iii) Glucose profile
during the glucose clamping experiment [44].
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3.2. Implantable Biosensors
An interesting and important application of biosensors is monitoring and measuring activity
inside the human body. This kind of sensors are denominated as implantable biosensors when
partially or fully introduced into the human body aiming to remain there for long periods of time
in a minimally invasive way. Implantable devices are another viable alternative for a continuous
monitoring, minimizing the pain and discomfort of the person.
In the near future, these implanted electronics will be an important tool in biomedicine, since it
can provide a clearer picture of the cascade of events occurring inside the body in a certain period of
time, helping monitoring chronic diseases, or progress after treatment and/or surgery. They can be
found in the body, heart, eyes, blood and brain.
Implantable biosensors have several advantages over other monitoring devices, since they can
monitor biological metabolites, nerve electrical stimulation, the detection of electric signals, restoring
body functions, and be used for drug delivery, between others directly from inside the biological
body [55]. A good example is monitoring blood pressure, an essential parameter in all organs of the
human body. A change in the pressure may result in a deteriorating or injury of the physiological
function. Hypertension and infarction are usual and serious health problems associated with the
function or dysfunction of the cardiac muscle. Investigations of implantable and miniaturized blood
pressure biosensors for continuous monitoring of hypertension and consequent efficient treatment are
being made [56].
Developing a fully implantable biosensor requires the integration of heterogeneous elements,
including electrodes for the recognition/sensing of the target analytes/vital signals, a circuit capable
of performing measurements and transmitting the data, and a power source. The final shape and
dimensions of the implantable biosensor must be biocompatible and well tolerated by the host, in order
to avoid toxicity and chronic inflammation [57].
Hence, one of the highest obstacles on the development of implantable devices delays on the
challenges associated with the mismatch between the hard, planar surfaces of semiconductor wafers
and the soft, curvilinear tissues of biological systems. They tend to easily damage the surrounding
tissues during insertion and exert chronic stress onto the adjacent biological environment, due to
their sharp edges, stiffness, design and size [58,59]. So, clearly, conventional sensors, partially or
fully rigid implants based on silicon wafer substrates, are more likely to be rejected and fouled.
These materials are described as causing formation of fibrous capsules around the system diminishing
the in vivo sensor performance, resulting in sensor failure [60–62]. Thus, for medical applications, it is
mandatory to promote a replacement of silicon wafers by biocompatible, soft and flexible substrates,
like biopolymer-based substrates, in order to alleviate that body-foreign issue and suppress fibrotic
tissue encapsulation [56,60]. Commonly used polymeric substrates are polyethylene naphthalate,
polyethylene terephthalateble and polyimide [63]. These polymer substrates are essential for devices
to overcome the mismatch between the hard, planar surfaces of semiconductor wafers and the soft,
curvilinear tissues of biological systems [64,65].
Additionally, to achieve a particular home-based monitoring, implantable devices should be
readily implanted and explanted in the body without the need of a complicated surgery. Under that
circumstance, the implantable device must be extremely small, which demand unprecedented
miniaturization of diverse functional components in order to fit in the implementation spot. If the
biosensor is too large, there is required an incision surgery, if it is small enough to fit, it can be delivered
by needle injection or via catheter [66]. These miniaturized biosensors implanted by needle-assistance
were proved to induce less tissue damage, less inflammation and foreign body response by Kvist el
al. [67]. Miniaturization is achieved through size reduction of sensing electrodes, driving electronics
for power generation, data communication and their subsequent integration/packaging. Consequently,
nanotechnology has been a potential and powerful avenue to accomplish components miniaturization
and integration down to the micro and nanometer level, involving for example, photolithography,
dip-pen nanolithography and micromachining techniques [60].
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When the biosensor is implanted in the human body, there will be immediately biofouling; and a
negative biological reaction as response to the foreign material itself known as FBR which are the
mainly responsible for the functionality loss of the device, resultant from the tissue trauma/damage
and poor biocompatibility of the sensor materials. According to many review articles, this negative
response of the body can depend on the diverse properties of the biosensor, including shape, size,
design, roughness, morphology and porosity, composition, interface material/device, sterilization,
time of implantation, packaging and degradation [66,68].
The negative FBR of the body involves a cascade of events, including typical wound healing
response, acute inflammation, chronic inflammation, and the formation of granulomatous tissue and
eventually excessive fibrosis [69,70]. Firstly, when a tissue/device interface is created, the nonspecific
blood and tissue fluids proteins adhere onto the surface or invade the materials. After that, it is the
turn of inflammatory and immune cells, such as leukocytes, monocytes and platelets, to react and
defend the body from the foreign object. These events are resultant from the acute phase, which may
last between hours and days. Chronic inflammation happens when there is an incessant presence
of the implantable device and thereby, continuous inflammation. In this phase, there is the action
of macrophages, monocytes, and lymphocytes, as well as blood vessels proliferating and connective
tissue restructuring the implant’s spot. The proliferation of blood vessels is important to wound
healing and supply of needed nutrients. The granulation tissue will be eventually replaced by an
extracellular matrix (ECM), which acts either as physical scaffold or an essential modulator of the
biological events, like differentiation, regeneration, repair and tumor progression. FBR finish when
there is a creation of a vascular, collagenous fibrous capsule around the implant that prevents the
interaction of the implantable device with surrounding tissues [68,71]. Therefore, if an abiotic material
is not well matched with the tissues and cells, and it is not biocompatible, the probability to remain in
place long term; it is very low and could also result in an unsafe effect on the body [66].
To modulate these body responses that affect the in vivo functionality and longevity of implantable
devices, several strategies have been reported [72–74], either passively via physicochemical features,
or actively with molecules or matrix. These studies have essentially focused on the use of biocompatible
material coatings, chemical surface modification of the device, conformable bioelectronics, steroidal
and nonsteroidal anti-inflammatory drugs and angiogenic drugs [71,75].
Surface modifications can be achieved by changing the terminal chemistry of the device and by
varying the roughness and surface topography. Functional groups, including hydroxyl, carboxyl,
amine, sulfonate or phosphate groups, can be created on the surface, thus reducing the adsorption
of some molecules. Probably, a single and simple surface modification alone will not be enough to
provide biocompatibility. Imprinting micro- and nano-patterns on the device’s surfaces may mimic
the natural topography of the ECM [71,75,76]. Yim et al. demonstrated that cells respond to the
topography of substrates, in terms of adhesion, proliferation, migration, and gene expression [77].
3.2.1. Glucose Sensors
Several biocompatible materials, such as chitosan, alginate, cellulose, heparin and silk, have been
employed as anti-fouling coating layers to act as a barrier against inner body elements such as
cells, proteins, platelets, and chemical gases and still isolate the inner electrical and mechanical
components. The coating membranes should maintain a desired and constant flux of permeation of
analyte molecules over long periods of time; reduce protein adsorption; and promote the integration of
the sensor with the surrounding tissues. They also must be thin and porous enough to allow the quick
answer of the sensor to variations in analyte concentration. An example of one membrane with those
characteristics was developed by Tripnis et al. [78], which consists of a layer-by-layer semipermeable
membrane for amperometric glucose biosensors where the modification of the number of its bilayers,
made possible the modulation of the diffusion of glucose toward the sensor. Another one was
presented by Vallejo-Heligon et al. [79], that used a porous polyurethane coatings, and they concluded
that when decreasing coating porosity increased sensor signal lag-time and attenuation (Figure 3a).
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Xie et al. [80] demonstrated that coating a continuous glucose monitor sensor with a zwitterionic
polymer, via a combinatorial-chemistry approach, significantly reduces signal noise, improving sensor
performance, and significantly reduces the immune response to the sensor [80]. Zwitterionic polymers
present ultra-low fouling properties and hinder non-specific protein adsorption, leading to reduced
capsular formation when implanted [81]. However, some of the non-toxic biocompatible materials
can eventually evoke a host immune response [60,76,82]. Tissue engineering approaches, based on
the use of biocompatible hydrogels as extracellular matrices to recreate cell microenvironments
and synergistically build and grow 3D tissue-like structures with embedded electronics, can be a
parallel alternative to reduce the fibrotic tissue formation after implantation. Hydrogels have been
engineered to recreate cell microenvironments to construct 3D tissue-like structures; due to their
similarities in terms of high water content and physical properties, they resemble the extracellular
environment of natural soft tissue [83,84]. The Papadimitrakopoulos group [82] studied a novel
polymer coating based is also required on poly(lactic-co-glycolic) acid (PLGA) microspheres, dispersed
in PVA hydrogels to prevent the FBR, and thus enhance sensor performance in vivo (Figure 3b).
Means et al. [85] reported a membrane with an “actively antifouling” or “self-cleaning” mechanism to
inhibit cellular attachment through continuous, cyclic deswelling/reswelling, in response to normal
temperature fluctuations of the subcutaneous tissue. This thermoresponsive double network membrane
is based on N-isopropylacrylamide (NIPAAm) and 2-acrylamido-2-methylpropane sulfonic acid
(AMPS). After examining the FBR at 7, 30 and 90 days after implantation, the thermoresponsive
membrane implants demonstrated a rapid healing response and a minimal fibrous capsule (~20–25µm),
which could be applied to extending the lifetime of sub-Q glucose biosensors [85].
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Figure 3. Strategies for reducing foreign body response (FBR) in implantable bio ensors.
(a) Dexamethasone-releasing polyurethane coatings for glucose sensors. Micro-CT images of p rous
coatings create via the salt-leaching/gas-foaming technique with decreasing porogen fraction.
The images show coatings of different morphologies created by varying the a monium bicarbonate
porogen concentration. (i) (ii) 90%, (iii) 60% and (iv) 30% [79]. (b) In vitro release profiles of
poly(lactic-co-glycolic) acid (PLGA) microspheres and PLGA microsphere/PVA hydrogel composite
coatings (n = 3 ± SD) at 37 ◦C, phosphate buffer solution in Polymeric “smart” coating for glucose
sensors [82].
Heo et al. developed a fluoresc nce- ased s nsor made of polyethylene glycol (PEG)-bonded
polyacrylamide (PAM) hydrog l fibers, able to reduce inflammation when compared with PAM
hydrogel fibers, which allows the continuous response to blood glucose concentration cha ges for up
to 140 days. The implanted fiber remains at the implantation site and transmits fluorescent signals
transdermally, according to glucose concentration, in blood, and can be easily removed to avoid
potential side effects (Figure 4) [86].
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Figure 4. In vivo continuous l c se itoring in mice using the implanted fibers. (a) Schematic
illustration of the fluorescent hydrogel fiber designed for long-term in vivo glucose onitoring. (b) The
fluorescent polyacrylamide (PAM) hydrogel fibers with and without polyethylene glycol (PEG) were
implanted in mouse ears and remained in the mouse ears for one month. The fluorescence intensity of
the fiber with PEG was observable through the ear skin for the entire month, whereas the fluorescence
intensity of the fiber without PEG was barely detectable after one month. (c) Continuous glucose
monitoring using implanted fibers and fluorescence intensity after implantation and after 140 days [86].
Yoon et al. developed a stainless-steel based non-enzymatic glucose sensor and a compact
wireless continuous glucose monitoring system, through the modification of flexible stainless-steel
(Figure 5). The flexible stainless-steel was highly effective in improving the adhesion between the metal
layer and substrate. Authors monitored interstitial fluid (ISF) glucose values, at 5–15 min intervals,
by subcutaneous implantation of the developed system. The comparison of the measured ISF glucose
with blood glucose determined by the Clarke error grid analysis was performed, and reveale that
82.76% of the measured glucose was within zone A. The biocompatibility of the developed bios nsor
was proven by hematoxylin and eosin staining, and pro-inflamma ory cytokines confirmation [87].
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Figure 5. In vivo investigation of the developed non-enzymatic continuous glucose monitoring system.
(a) Photograph of the developed non-enzymatic continuous glucose monitoring (CGM) and MiniMed
CG as a reference, which were implanted on a rabbit. (b) ISF glucose values measured using the
MiniMed CGM (black line with square) and the developed non-enzymatic CGM (red line with circle)
in animal experiment [87].
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3.2.2. Bio-Potential Sensors
Conformable devices able to reduce the mechanical mismatches between the implant and the
biological tissue have also been used as a strategy to overcome FBR in implantable biosensors [72].
For example, Wang et al. [88] reported on functionalized multi-walled carbon nanotubes twisted into
helical fiber bundles that mimic the hierarchical structure of muscle and allow the monitoring of
multiple disease biomarkers in vivo. The flexible fiber bundles are injectable, have a low bending
stiffness and display ultralow stress under compression. When injected into tissue, the sensor formed
a stable fiber-tissue interface and showed good biointegration, offering a robust tool for long-term
sensing applications [88]. In another example, Bai et al. reported a silicon-based, bioresorbable
photonic platform that relies on thin filaments of monocrystalline silicon encapsulated by polymers
as flexible, transient optical waveguides for accurate light delivery and sensing at targeted sites in
biological systems [89].
Another current method to control and/or minimize the body response is to incorporate bioactive
molecules such as growth factors, anti-inflammatory mediators or drugs, to prevent the deposition
of proteins on the surface of the device. The coupling of anti-inflammatory drugs to the device
provides the release of the drug directly on the affected tissue [68,75]. Jayant et al. developed a
system that can concurrently deliver 100% anti-inflammatory drugs (dexamethasone and diclofenac
sodium) encapsulated in alginate microspheres, for use in implantable “Smart tattoo” biosensors to
continuous glucose monitoring [90]. Coatings with combinations of three tissue response modifiers
(TRMs): dexamethasone, VEGF (vascular endothelial growth factor) and PDGF (platelet derived growth
factor) were prepared by the Papadimitrakapoulos group [91], in order to TRMs be delivered and
prevent FBR and promote angiogenesis and blood vessel maturation around subcutaneous implants.
Vallejo–Heligon et al. [92] investigated implanted glucose sensors coated with dexamethasone-loaded
porous polyurethane coatings that combined angiogenic texturing with the local delivery of the
anti-inflammatory agent to achieve the dual effect of curbing inflammation, and promoting the
vascularization around indwelling sensors.
Regarding implantable biosensors and strategies to overcome FBR, it is also important to consider
the sterilization of the material surface, before the implantation, concerning the elimination of
harmful microorganisms through dry heat sterilization, pressured vapor sterilization, ethylene oxide
sterilization, gamma radiation sterilization, and others [68].
3.3. Power Supply
One of the most critical challenges for the appropriate functioning of active implantable medical
devices is the powering. The energy consumption of these devices is among microwatts to milliwatts.
The power source is also a major contributor to the overall weight and size of the device, but with the
advancements in MEMS (microelectromechanical systems) and nanotechnology, the electronic circuitry
components have decreased dramatically [61,93,94].
Conventional implantable devices are usually powered by an external system, like bulky and
heavy batteries which need replacement through surgeries because of the short service life, or by
using direct transcutaneous wires which poses the risk of infections and may cause discomfort and
restriction of movements to the patient [95,96]. Furthermore, conventional powering systems have
limited utility due to discrepant contact with the crimpy and curved surfaces of organs such as the
heart, brain, eye, and lung [97]. Regarding that, and aiming to be long-lasting, autonomy, real-time
monitoring, and implantable devices need an innovative power supply. Plus, applications in retinal
and cochlear implants, deep brain stimulators for epilepsy and Parkinson’s disease, pacemakers and
brain-machine, demand indwelling power sources, in order to allow implantable devices to work
for several years in vivo with a limited power, and without any intervention or maintenance on the
hardware [98]. As a consequence, several technologies have been investigated in order to improve
these powering methods. Wireless powering is the most used method and is capable to yield high light
power densities [99]. This approach has been focused on two wireless methods, far-field and near-field,
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meaning the distance between the source and the device as a function of the powering frequency.
Far-field is based on electromagnetic waves propagation captured at distances far from the source.
Consequently, this type of powering is more relevant for devices located at greater distances, and when
the power supply is not worn by the patient. Although, wireless implantable medical devices use
near-field coupling since is a more efficient powering. This method uses inductive techniques and
much lower frequencies to transfer and capture energy. To optimize these low frequencies, using energy
harvesting technologies in terms of power conditions circuits becomes a critical task and technologies
are emerging to face this drawback, like the use of triboelectric nanogenerators [100–102]. Near-field
powering is a better fit for devices that require high power consumption and with non-relevant size,
like sophisticated closed-loop neural prostheses [88]. However, these two wireless powering methods
have restraints, since the impedances of the both transmitting and receiving coils are sensitive to the
distance and the orientation between them, likewise the electrical properties of the bio-tissues between
the coils [99,103].
For the extreme miniaturization of devices that aim to be implanted in deep tissue spaces, Ho et
al. demonstrated a method that can overcome those near-field and far-field limitations. The method is
based on a termed midfield powering, to create a high-energy density region deep in tissue, inside
of which the power-harvesting structure can be made extremely small. This method will enable
the possibility of new generations of implantable systems that can be integrated into the body at
minimal cost and risk [104]. However, Jiang et al. have suggested a novel low-frequency wireless
power transfer technology using rotating rare-earth permanent magnets that are suitable for the
near-field wireless power transfer to biomedical implants [103]. Moreover, Bakula et al. successfully
demonstrated the combination of multiple requirements, such as low power, small size, power and
frequency adaptability in one implant control system, based on a Royer oscillator with RF and near-field
communication links [105]. He et al. proposed a wireless power supply based on a MEMS-based
ultrasonic transducer with piezoelectric thick film [106]. Finally, Shon et al. developed an implantable
wireless neural interface system for simultaneous neural signal recording and stimulation using a
single cuff electrode (Figure 6a). The system also includes a wireless power consortium-compliant
power transmission circuit and a medical implant communication service-band-based radio link.
The maximum reliable operating distance for wireless power transmission was, approximately, 11 mm,
and the overall efficiency corresponded to 67%, which is higher than conventional wireless power
transmission devices [107].
Another interesting method is to harvest the energy of physiological processes or the body’s
biomechanical motions, including vibration due to the movement of the patient, vibrational energy
of breathing, cardiac/lung motions, muscle contraction/relaxation or blood circulation. Implantable
devices powered by harvested energy have longer lifetimes and afford more comfort and safety
than conventional devices. Thus, this method can be attained to battery-less implants, where is
possible to directly power the device through the harvested energy from natural or artificial power
sources surrounding the patient [61]. Different human body activities are sources of kinetic and
thermal energies, and consequently producers of different levels of power. Kinetic energy harvesting
bases on collect energy associated to human motions and converts it into electrical energy through
piezoelectric, magnetic induction generator and electrostatic transduction methods [108]. Hwang et
al. introduced a flexible and high-performance piezoelectric energy harvester enabled by a single
crystalline PIMNT (indium modified crystalline Pb(In1/2Nb1/2)O3-Pb(Mg1/3Nb2/3)O3-PbTiO3) thin
film on a PET (polyethyleneterephthalate) substrate (Figure 6b), which used mechanical deformation
and biomechanical motion [109]. Park et al. fabricated a highly-efficient, flexible, lightweight,
and large-area piezoelectric PZT thin film nanogenerator on PET substrate [110]. Shin et al.
demonstrated high-performance flexible piezoelectric nanogenerators based on a composite thin
film composed of hemispherically aggregated BTO nanoparticles and p(VDF-HFP) [111]. Karker et
al. presented a plasmonic-based energy harvesting from chemical sensors where thermal energy is
harvested using lithographically patterned gold nanorods [112]. Biocells are also power sources that
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can be employed in the human body, implementing biological analytes as catalysts at the anode and
cathode. They are capable of mimicking many of the metabolic pathways, thus extracting electrical
energy from energy sources naturally found in biological fluids [113]. Ghosh et al. developed a
self-powered wearable bio-inspired piezoelectric biosensor, based on collagen nano-fibrils, which could
transduce the minute deformation of human skin. The developed energy harvester acts as a sensor
that interacts with human body parts to monitor real-time physiological signal, such as, arterial pulses,
vocal cord vibration and gentle wrist movements [114].
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Figure 6. Power supply strategies for implantable biosensors. (a) Sensor implantation: (i) cuff electrodes
wrapped around the tibial and peroneal nerves and (ii) implantable device inserted under the back
skin of a rabbit [107]; (b) Deep brain stimulation (DBS) applications using the flexible indium modified
crystalline Pb(In1/2Nb1/2)O3-Pb(Mg1/3Nb2/3)O3-PbTiO3 (PIMNT) energy harvester and characteristics
of the flexible PIMNT film (i) a schematic illustration of DBS applications using the flexible PIMNT thin
film energy harvester and (ii) a photograph of the final flexible PIMNT harvesting device completely
bent by human fingers [109].
Du Toit and Lorenzo reported two innovative constant flow enzymatic biofuel cell configurations
that employ highly porous gold electrodes and glucose oxidase and laccase as the catalysts providing
that way continuous power generation [115]. Zebda et al. described an original design of a glucose
biofuel cell, based on carbon nanotube/enzyme electrodes, which had a successful implantation in
a rat and pro uced significant levels of nergy at a single location [116]. D ng et al. focused on
providi g power for implantable me i l devices using a mic obial fuel cell implant d in human
transverse colon [93]. More recently, Wu et al. developed a wireless implantable sensor prototype
with subcutaneous solar energy harvesting. This system is based on a power management circuit,
a temperature sensor, and a Bluetooth low energy module. The results shown that the solar sensor
can output tens of microWatts to a few milliWatts, depending on the light conditions and in the
implantation zone, being the most accurate between the neck and shoulder [117].
In general, to develop energy harvesting methods, it is expected that electronic technology
continues its evolution of decreasing energy consumption. Harvesting techniques and their application
are in constant expansion and are becoming more attractive.
3.4. Data Communication
Post implant monitoring is an essential factor for the implantable devices and patient care. Remote
monitoring fills the gap of the lack of information resultant from the conventional follow-up visits,
providing large prospective trials, automatic daily transmissions and long-term support at a distance,
allowing the patient to be at home [118].
Advances on implantable medical devices are demanding, since the methods to translate the
follow-up observations are time consuming and complex. Better methods to transmit the collected
data obtained are urging for further developments in implantable devices. A considerable increasing
in the density of analysis and interpretation/processing algorithms is also required [61]. The devices
are equipped with a micro-antenna for communication and thereby the sensed data are remotely
transmitted to an external system, such as a computer, smartphone or tablet and network, like wireless
body area networks (WBAN). The antenna may be built up by flexible materials and consequently,
flexible coils, to improve the biocompatibility and conform to the inner body and organs.
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Various developments of data transmission have occurred over time, starting from fax reports
to a social networking service system, from wired system to wireless communication, and from
one-direction transmission to bidirectional transmission [119]. Since wires are related to surgical
complications due to their probability to break, become infected or introduce electrical noise in the
recording by motion artifacts or by antenna effects, wireless communications have emerged to avoid
those complications [120]. Wireless communication can be achieved by using radio frequency (RF),
optical, sound, or infrared media, although RF is the most common [121]. Wireless RF telemetry
also depends upon a considerable power and can experience poor transmission through biological
tissue. Wireless data transmissions through electromagnetic induction, or light were developed,
but they have troubles transmitting the data when the external data transmission unit alters from its
proper position; therefore, other methods are being developed [122]. The community for medical
devices normally assigns specific bands for the wireless communication of implantable devices,
such as a very high frequency band at 174–216 MHz, an ultrahigh frequency bands at 401–406 MHz
and 450–470 MHz, and other narrow bands within the industrial, scientific and medical bands of
6.765 MHz to 245 GHz [121]. A recently wireless communication employed to transmit signals is the
intrabody communication, which uses the conductive properties of the body. In this case, signals can
be transmitted from the implanted device, either to electrodes mounted on the skin or to receiver
electrodes also implanted inside the body. This implanted receiver can be connected to external
equipment using wireless RF telemetry. In this way, less power is required to transmit to the implanted
receiver electrodes [120]. Nevertheless, inductive method communication is the most applied in
applications where the sensor element is implanted deeper into the body [56].
Asgari et al. integrated an antenna, a transceiver unit and a wireless network algorithm to
enable their left ventricular assistance devices to establish a reliable telemetry communication with
an extracorporeal platform, such as a smartphone, tablet or personal computer [123]. Kilinc et al.
presented a system for wireless power transfer and data communication of battery less biosensor
systems implantable in small animals, based on an implant coil placed to induce AC voltage from the
available magnetic field [124]. Ryou et al. developed an endoscopically implantable biosensor for real
time detection of UGIB equipped with a radio and antenna capable of transmitting out of the body
and wirelessly linked to an external computer and transceiver [125]. Aldaoud et al. implemented a
miniaturized wireless blood pressure sensor interface which used capacitive coupling to transmit the
sensed data, as well as wireless inductive powering [126]. Olivo et al. tested by micro-fabrication
high-thickness spiral inductors for the remote powering of implantable biosensors through inductive
link. These inductors enabled bidirectional data communication with the external transmitter [127].
Luo et al. successfully designed and microfabricated a RF wireless LC resonant pressure sensor
completely made of biodegradable materials. Here, an inductor coil acts not only as an essential
component of the resonant sensor, but also gives routes for magnetically coupling the sensor to a coil
outside the body [128].
Additionally, to have an accurately reading, analysis and monitoring of signals from the human
body, there is a requirement of sensitive transducers, filter and amplification units [129].
Lee at al. developed an implantable device to sense electrocardiogram signal, but also the voltage
level of the secondary cell and temperature inside the implantable device, being the data transmitted,
by RF link, to a PC program or a mobile application. Of the several frequency bands, the medical
device radio communication service has been allocated in the 401–406 MHz for data transmission [130].
Mulberry et al. developed a CMOS (complementary metal–oxide–semiconductor) chip mounted
into a polyimide flexible printed circuit board for a neural recording implant (Figure 7a); this flexible
substrate enables the system’s wireless power transfer by using spiral traces as an inductive coil.
Additionally, it holds a system-on-chip (SOC) that operates the CMOS chip (Figure 7b) and sends data
wirelessly via Bluetooth low energy (BLE) to a computer. The SOC contains an ARM microcontroller,
which generates the required timing signals to operate the CMOS neural chip and processes and
packages the data it receives to send via BLE [131].
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More recently, Vennemann et al. developed an implantable magnetic blood flow sensor (Figure 7c),
being the wirelessly transmitted to the patient’s smartphone for in-depth processing. The wireless
operation could be sustained as long as an NFC (near field communication)-enabled smartphone is in
the vicinity of the implant and transmitting power through inductive coupling [132].Biosensors 2020, 10, x FOR PEER REVIEW 17 of 28 
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neural interface, (iii) the bottom side of the neural interface [131] and (c) illustration of the heart valve
monitoring system, which communicates the data by wireless [132].
3.5. Fabrication Methods and Current Applications
Essentially, remarkable advances in implantable biosensors have been achieved through the use of
the combination of electrical active matrices on flexible polymeric substrates. To make them so potential
and multifunctional, various fabrication methods are currently available [133]. Microfabrication
methodology includes several processes used in the fabrication of semiconductors and integrated
systems. Among these processes, photolithography, deposition techniques, doping and etching stand
out. Over the past years, this technology extended also for the development of small-scale miniaturized
devices, and it has been extensively applied to fabricate icro-engineering surfaces, sensors and
transistors, MEMS, micro-opto-electro-mechanical systems (MOEMS), and als in the fabrication of
flexible and tretchable devices [134]. For example, Theodo et al. reported a sensor system f the
continuous monitoring of blood pressure using an acceleration implanted on a rt ry using
minimally invasive chniques. The sensor system is based n a flexible polyimide substrate with
photolithographically structured copper tracks glued by thin layers of epoxy adhesive to both sides of
the polyimide substrate. A surrounding polyimide layer covers and electrically isolates the copper
tracks. Mounting of the electronics to the substrate is performed by opening of the insulating layer
and reflow soldering. A surrounding layer of biocompatible parylene-C is deposited and protects the
circuit from body fluids and the organism from ions of the circuit (Figure 8a) [135]. Table 1 shows
several examples of current applications in the field of implantable devices, with respective materials
and the common features of fabrication technologies. Regarding the exposed information on the table,
the most frequent methods are related to conventional micromachining technologies, such as chemical
vapor deposition (CVD), physical vapor deposition ((PVD)—evaporation and sputtering), etching
and reactive ion etching (RIE), thermal oxidation. Besides those, there is also the presence of printing
methods, essentially screen an transfer printing. For example, Viventi at al. report th development
of a class of mec anically flexible ilicon electron c for the multiplexe measurement f signals in an
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intimate, conformal integrated mode on the dynamic, three-dimensional surfaces of soft tissues in the
human body. The fabrication consisted of doped single crystal silicon nanoribbons on a silicon wafer
that are transfer-printed to a thin plastic sheet. The deposition and patterning of suitable dielectric and
metal layers complete the functional electronics, and specialized designs and multilayer encapsulation
schemes protect all active components from the tissue and surrounding biofluids (Figure 8b) [136].
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Figure 8. Fabrication techniques of implantable biosensors. (a) Structure of the polyamide foil with Cu
tracks, mounted sensor and encapsulation in Implantable accelerometer system for the determination
of blood pressure [135]. (b) Schematic illustrations and images of steps for fabricating active, conformal
electronics for cardiac electrophysiology. (i) Schematic illustration (left) and optical micrograph (right)
of a collection of doped silicon nanomembranes in a unit cell. (ii) Configuration after fabrication of
the source, drain, and gate contacts, with suitable interconnects and row electrodes for multiplexed
addressing. (iii) Configuration after fabrication of the second metal layer, including the column
output electrodes. (iv) Final layout after deposition of encapsulation layers and fabrication of the
tissue-contacting electrode [136].
Patterning electronics materials on diverse flexible substrates through printing technologies has
received greater attractions. Usually, there are two ajor approaches of printing system; contact
and non-contact printing. In contact printing, as the name says, there i a physical ontact between
patterned structures havi g inked surfaces, with the substrate. This process includes n no-impri ting,
transfer printing, micro-contact printing technol gies, and others. By contrast, in a non-contact
appr ach, the solution is poured through op nings or nozzl s, a d by moving the substrate holder
in pre-programmed pattern, structures can be obtained. In this one, techniques like screen printing,
inkjet printing and slot-die printing can be attributed [137]. For example, Viventi et al. developed new
devices that integrate ultrathin and flexible silicon nanomembrane transistors into the electrode array,
enabling new dense arrays of thousands of amplified and multiplexed sensors that are connected using
fewer wires to record and stimulate the brain. These devices were fabricate using a multi-layer process,
where doped silicon nanomembranes, structured into ribbons, were located in the first layer through
the use of transfer printing technology [138]. In another example, Kim and Viventi et al. reported
a material strategy for a type of bio-interfaced system that relies on ultrathin electronics supported
by bioresorbable substrates of silk fibroin. For this, com ercial polya ide films were attached to
a temporary carrier substrate consisting of a glass slide coated with PDMS. Then, electron beam
eva or tion form d u iform coatings of metal (Cr/Au, 50/1450 A). Photolithography and patterned
etching yielded arrays of interco nect lines. Thin layers of polyamid were s in-c s and patterned by
reactive ion etching le t only the ends f he line expose . Further deposition and patt rning d fined
square metal electrode pads at these locations. Peeling these away from the PDMS-coated glass slide
and bonding them to an ACF cable completed the fabrication [139].
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Table 1. Summary of applications and fabrication methods of implantable devices.



































Carotid artery Monitoring of blood pressure Cu electrodes PI substrate Photolitography [135]
Brain
Mapping brain signals Au electrode patterns PI (mesh) Silk(dissolvable substrate) Photolitography/Ecthing [139]
Mapping neuronal activity Pt electrodes (contact) Auelectrode (base) PI (substrate)
E-beam Evaporation/
CVD/Transfer Printing [138]
Neuronal imaging; optogenetic Graphene Au connection pads Parylene C CVD/E-beam evaporation/RIE [142]
Brain-machine interface; spinal






Glutamate sensing Pt electrodes PDMS
Photolithography/E-beam
evaporation/Etching [144]





Carbon fiber Electropolymerization [146]
Eye Retinal stimulation Boron doped diamond electrodes PI (substrate) SiO2(sacrificial layer) CVD/Etching [147]
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Table 1. Cont.









Bovine haptoglobin measurement Gold nanoparticles Multi-walledcarbon nanotube Paper Printing [148]
Subdermal
dorsal region Thermal therapy




substrate) Transfer Printing/PVD [58]
Peripheral
nerve
Glucose sensor for inflammation
monitoring
Pt (working electrode) Ag/AgCl
(reference electrode) PI substrate
RIE/Sputtering/
Photolitography [149]
Table Legend: Si—Silicon; PI—Polyimide; PZT—Lead Zirconate Titantate; Au—Gold; PDMS—Polydimethylsiloxane; Cr—Chromium; Pt—Platinum; Ti—Titanium; Cu—Copper;
SiO2—Silicon oxide; GaAr—Gallium argonide; PVA—Poly(vinyl alcohol); Mg—Magnesium; MgO—Magnesium oxide; Ag—Silver; AgCl—Silver chloride.
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4. Conclusions and Future Directions
Biosensors are devices capable of detecting target analytes in a sample mixture. They are composed
of bioreceptors, and transducers, responsible for the production of a specific signal, that will after
be processed in a readable output signal. Biosensors can be applied to a variety of fields, however,
monitoring health conditions is their most attractive application. They can be used for early diagnosis
and continuous monitoring of high mortality diseases, such as cancer and cardiovascular diseases,
significantly contributing to a reduction on mortality rate and the improvement of the patient’s
life quality.
Skin-integrated and implantable biosensors envision the analyte detection in human fluids
and in loco, which in one hand can provide a more reliable and real time monitoring of the health
condition, and in the other hand it adds complexity and technical challenges to the biosensing system.
Skin-integrated biosensors can be mounted directly on skin or by using a flexible polymer that will
mechanically match skin. Several micro-fabrication techniques and nanomaterials have been used to
produce multiple skin-integrated wearable devices, such as bio-potential sensors, sweat sensors and
tattoo sensors.
Implantable biosensors need to consider the FBR, which implies the choice of biocompatible
materials and fabrication methods. Therefore, biocompatibility and lifetime are the major limitations
besides the power methodologies. Approaches for harvesting energy from the body environment have
been investigated as an alternative to the conventional battery-based systems for powering the wearable
and implantable biosensors. Although, challenges like low output power and restricted implant
location choices need to be overcome. On the other hand, power approaches related to inductive
coupling or the ultrasonic transducer may allow transferring the power and information data in
addition, to the ability to power the devices in different body locations. Nevertheless, there is still room
for improvement and optimization in the field of wireless communications and wireless powering.
Significant advances have been made in the field of skin-integrated and wearable biosensors,
however, the complexity and multidisciplinary nature of the field leave many technical challenges still
to solve. Therefore, finding new ways to avoid FBR, produce sustainable power supplies and data
communication are areas where more research needs to be performed, in order for these devices to
achieve real world applications.
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